Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5192843
Max Phase: Preclinical
Molecular Formula: C64H60Cl2F5N9O6
Molecular Weight: 1217.14
Associated Items:
ID: ALA5192843
Max Phase: Preclinical
Molecular Formula: C64H60Cl2F5N9O6
Molecular Weight: 1217.14
Associated Items:
Canonical SMILES: COc1cc(C(=O)NCc2ccc(CNC(=O)c3ccc(-c4ccc(N5CCN(C)CC5)c(NC(=O)c5c[nH]c(=O)cc5C(F)(F)F)c4)cc3)cc2)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F
Standard InChI: InChI=1S/C64H60Cl2F5N9O6/c1-62(2,3)31-53-63(35-72,45-20-19-42(65)29-48(45)67)55(43-7-6-8-47(66)56(43)68)57(78-53)61(85)76-49-21-17-41(28-52(49)86-5)59(83)75-33-37-11-9-36(10-12-37)32-74-58(82)39-15-13-38(14-16-39)40-18-22-51(80-25-23-79(4)24-26-80)50(27-40)77-60(84)44-34-73-54(81)30-46(44)64(69,70)71/h6-22,27-30,34,53,55,57,78H,23-26,31-33H2,1-5H3,(H,73,81)(H,74,82)(H,75,83)(H,76,85)(H,77,84)/t53-,55-,57+,63-/m0/s1
Standard InChI Key: AGGHHLIITFMNSV-CYFXLULWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1217.14 | Molecular Weight (Monoisotopic): 1215.3964 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dölle A, Adhikari B, Krämer A, Weckesser J, Berner N, Berger LM, Diebold M, Szewczyk MM, Barsyte-Lovejoy D, Arrowsmith CH, Gebel J, Löhr F, Dötsch V, Eilers M, Heinzlmeir S, Kuster B, Sotriffer C, Wolf E, Knapp S.. (2021) Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders., 64 (15.0): [PMID:33980013] [10.1021/acs.jmedchem.1c00146] |
Source(1):